Biochemical and Molecular Mechanisms in the Development of Diabetic Vascular Complications
George L. King(Joslin Diabetes Center), Pu Xia(Integrated Chinese Medicine (China)), Yoshihiko Nishio(Shiga University of Medical Science), Toyoshi Inoguchi(Kyushu University), Makoto Kunisaki(Joslin Diabetes Center), Teruo Shiba(Joslin Diabetes Center)
Cited by 130
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979